Iskra Pusic, MD, MSCI

Iskra Pusic, MD, MSCI

Bone Marrow Transplant Specialist, Medical Oncologist

Primary Academic Title

Associate Professor of Medicine, Division of Oncology, Section of Bone Marrow Transplantation, WashU Medicine

Clinical Expertise

Bone marrow transplantation, graft-versus-host disease, leukemia, myelodysplastic syndrome

Research Interest

Hematologic malignancies, stem cell transplantation and graft-versus-host disease.

Education

  • 1997: MD, University of Zagreb, Zagreb, Croatia
  • 2015: MS in Clinical Investigation, Washington University, St. Louis

Training

  • 1997 - 1998: Intern, University Hospital Center, Zagreb, Croatia
  • 2001 - 2004: Resident, internal medicine, State University of New York Downstate Medical Center, New York
  • 2004 - 2007: Fellow, hematology and oncology, State University of New York Downstate Medical Center
  • 2007 - 2008: Fellow, bone marrow transplantation and leukemia, Washington University, St. Louis

Board Certification

  • 2008: American Board of Internal Medicine, Medical Oncology
  • 2009: American Board of Internal Medicine, Hematology

Selected Research Publications

Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response.
  • Jacoby MA, Duncavage ED, Khanna A, [...] Pusic I, [...] Walter MJ
  • Leukemia 2025
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease.
  • Wolff D, Cutler C, Lee SJ, Pusic I, [...] Kitko CL
  • N Engl J Med 2024
CML and the WHO: Why?
  • Berman E, Shah NP, Deninger M, [...] Pusic I, [...] Druker B
  • J Clin Oncol 2024
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
  • Shah NP, Bhatia R, Altman JK, [...] Pusic I, [...] Gregory K
  • J Natl Compr Canc Netw 2024
Patient-reported treatment response in chronic graft-versus-host disease.
  • Im A, Pusic I, Onstad L, [...] Pidala J
  • Haematologica 2024
Acute Graft-versus-Host Disease: An Update on New Treatment Options.
  • Patel DA, Crain M, Pusic I, Schroeder MA
  • Drugs 2023
Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy.
  • Ferraro F, Gruszczynska A, Ruzinova MB, [...] Pusic I, [...] Welch JS
  • Haematologica 2022

Contact Information

  • Gary C. Werths Building at Siteman Cancer Center

    4500 Forest Park Avenue
    Saint Louis, MO 63108

Phone Numbers

Request an appointment